PROSPECTIVE MARKERS IN TRAUMATIC BRAIN INJURY (TBI)

摘要

The invention provides an in vitro prospective method for determining a recovery outcome in one or more samples of a subject having experienced traumatic brain injury (TBI), comprising the steps of a) determining the level of at least one biomarker selected from the group consisting of H-FABP, IL-10, GFAP, NF-L and S100B; and b) comparing each level obtained under step a) with a corresponding reference value to determine the recovery outcome. The invention also provides a device comprising an assay for determining a recovering outcome in one or more samples of a subject having experienced traumatic brain injury (TBI), the assay comprising means for detecting the level of at least one biomarker selected from the group consisting of H-FABP, IL-10, GFAP, NF-L and S100B.